# Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis

> **NCT05711290** · NA · COMPLETED · sponsor: **University of Oxford** · enrollment: 28 (actual)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** Oxygen Nanobubble
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05711290
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-21
- **Primary completion:** 2023-08-08
- **Final completion:** 2023-08-09
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05711290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05711290, "Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05711290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*